Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Teijin Pharma aggregated by PharmaCompass.com.

    Client Virtual Booth

    TEIJIN PHARMA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Teijin Pharma
    japan Flag
    Country
    Country
    Japan
    Address
    Address
    3-2-1 Kasumigaseki Chiyoda-Ku
    Telephone
    Telephone
    81-3-3506-4077
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.teijin-pharma.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Japan's Teijin inks $230 M deal with Novartis for kidney diseases treatment
    Japan's Teijin inks $230 M deal with Novartis for kidney diseases treatment

    https://www.biospectrumasia.com/news/25/22070/japans-teijin-pharma-inks-230-m-deal-with-novartis-for-kidney-diseases-treatment.html

    BIOSPECTRUM ASIA
    08 Mar 2023
    Share Share
    Teijin and Axcelead to establish drug discovery research JV
    Teijin and Axcelead to establish drug discovery research JV

    https://www.indianpharmapost.com/news/teijin-and-axcelead-to-establish-drug-discovery-research-jv-13760

    INDIAN PHARMA POST
    21 Feb 2023
    Share Share
    Teijin Pharma Receives Approval Japan for Abaloparatide Acetate for Osteoporosis
    Teijin Pharma Receives Approval Japan for Abaloparatide Acetate for Osteoporosis

    https://www.teijin.com/news/2022/09/05/20220905_01.pdf

    PRESS RELEASE
    05 Sep 2022
    Share Share
    Iktos, Teijin Pharma to Co-Develop New Technology for SMD Discovery
    Iktos, Teijin Pharma to Co-Develop New Technology for SMD Discovery

    https://www.businesswire.com/news/home/20220404006084/en

    BUSINESSWIRE
    05 Apr 2022
    Share Share
    Teijin Receives Additional Approval in Japan for Merz's Xeomin® Botulinum Toxin
    Teijin Receives Additional Approval in Japan for Merz's Xeomin® Botulinum Toxin

    https://www.businesswire.com/news/home/20210623005445/nl

    BUSINESSWIRE
    23 Jun 2021
    Share Share
    Teijin receives additional approval in Japan for botulinum toxin type A Xeomin
    Teijin receives additional approval in Japan for botulinum toxin type A Xeomin

    https://www.businesswire.com/news/home/20210623005963/fr

    BUSINESSWIRE
    22 Jun 2021
    Share Share
    Takeda Completes Sale of Four Diabetes Products in Japan to Teijin Pharma
    Takeda Completes Sale of Four Diabetes Products in Japan to Teijin Pharma

    https://www.takeda.com/newsroom/newsreleases/2021/takeda-completes-sale-of-four-diabetes-products-in-japan-to-teijin-pharma-limited/

    PRESS RELEASE
    02 Apr 2021
    Share Share
    Takeda sells Japan’s non-core products portfolio to Teijin Pharma
    Takeda sells Japan’s non-core products portfolio to Teijin Pharma

    https://www.pharmaceutical-technology.com/news/takeda-japans-non-core-teijin-pharma/

    PHARMACEUTICAL-TECHNOLOGY
    01 Apr 2021
    Share Share
    Takeda Completes Sale of Four Diabetes Products in Japan to Teijin Pharma
    Takeda Completes Sale of Four Diabetes Products in Japan to Teijin Pharma

    https://www.takeda.com/newsroom/newsreleases/2021/takeda-completes-sale-of-four-diabetes-products-in-japan-to-teijin-pharma-limited/

    TAKEDA
    31 Mar 2021
    Share Share
    Japan's Takeda sells four diabetes products to Teijin Pharma for $1.25 billion
    Japan's Takeda sells four diabetes products to Teijin Pharma for $1.25 billion

    https://www.reuters.com/article/us-takeda-diabetes-sale/japans-takeda-sells-four-diabetes-products-to-teijin-pharma-for-1-25-billion-idUSKBN2AQ10Y

    Rocky Swift REUTERS
    27 Feb 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search